Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Aurinia Pharmaceuticals' Stock Is Up Big Today

TheMotleyFool

0 0

Why Aurinia Pharmaceuticals' Stock Is Up Big TodayPhoto, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

In response to receiving a favorable analyst rating, shares of Aurinia Pharmaceuticals (NASDAQ: AUPH), a clinical-stage biopharmaceutical company, rose 12% as of 3:55 p.m. EDT on Tuesday.

Investors can thank Justin Kim, an analyst at Oppenheimer, for today's double-digit jump. Kim initiated coverage on Aurinia Pharmaceuticals on Monday evening after the market closed and gave shares an "outperform" rating. A price target of $14 was also issued, which is considerably higher than the $5.80 closing share price on Monday.

Traders bid up shares in response to the bullish rating and sky-high price target.

Source Fool.com

Like: 0

AUPH

Teilen